BeOne Medicines Ltd
215 hedge funds and large institutions have $6.06B invested in BeOne Medicines Ltd in 2020 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 95 increasing their positions, 64 reducing their positions, and 31 closing their positions.
53% more call options, than puts
Call options by funds: $15.8M | Put options by funds: $10.3M
48% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 64
10% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 31
1.35% less ownership
Funds ownership: 6.27% → 4.92% (-1.3%)
3% less funds holding
Funds holding: 221 → 215 (-6)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
25% less capital invested
Capital invested by funds: $8.11B → $6.06B (-$2.05B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$181M |
| 2 |
Primecap Management
Pasadena,
California
|
+$110M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
+$51M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$49M |
| 5 |
Temasek Holdings
Singapore
|
+$27.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$159M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$67.4M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$55.5M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$46.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$38.3M |
ONC Hedge Fund Activity: Q1 2020 in Review
215 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2020, worth a combined $6.06B — down 25% from $8.11B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of ONC and 28 opened new positions — a net loss of 3 holders — while 64 trimmed existing stakes and 95 added.
The largest buyer was Capital International Investors, adding an estimated $181M. The largest seller was Vanguard Group, cutting an estimated $159M.
- 215 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2020, down from 221 in Q4 2019.
- Funds reported $6.06B of BeOne Medicines Ltd stock for Q1 2020, down 25% quarter-over-quarter.
- 28 funds opened new BeOne Medicines Ltd positions in Q1 2020 and 31 closed out, a net change of -3 holders.
- The largest BeOne Medicines Ltd buyer in Q1 2020 was Capital International Investors, an estimated $181M added.
- The largest BeOne Medicines Ltd seller in Q1 2020 was Vanguard Group, an estimated $159M sold.
Based on aggregated 13F filings for Q1 2020.